Jeffrey Ludwig
Corporate Officer/Principal en PUMA BIOTECHNOLOGY, INC. .
Fortuna: 673 296 $ al 31/03/2024
Perfil
Jeffrey Ludwig is currently the Chief Commercial Officer at Puma Biotechnology, Inc. Prior to this, he was the Vice President-Oncology Sales at Amgen, Inc. from 2014 to 2019 and at Astellas Pharma, Inc. from 2019 to 2020.
He completed his undergraduate degree at Arizona State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0.26% | 12/02/2024 | 127 037 ( 0.26% ) | 673 296 $ | 31/03/2024 |
Cargos activos de Jeffrey Ludwig
| Empresas | Cargo | Inicio |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01/03/2020 |
Antiguos cargos conocidos de Jeffrey Ludwig.
| Empresas | Cargo | Fin |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 01/01/2020 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2019 |
Formación de Jeffrey Ludwig.
| Arizona State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Jeffrey Ludwig
